Join PCNA on September 18, 2025, for a virtual educational summit, where cardiovascular nursing meets cutting-edge science and innovation. We’ll explore critical topics shaping patient care, including ATTR-CM, hypertension guideline updates, LDL-C, and Lp(a) management. We’ll also examine how artificial intelligence is transforming nursing practice and decision-making.
This summit is designed to equip you with the latest evidence-based knowledge to elevate your clinical impact and improve cardiovascular outcomes. Earn 3.0 CE contact hours.
Agenda
| Time | Session |
|---|---|
| 9:00 AM CT | Opening Remarks |
| 10:00 AM CT | Hypertension Reimagined: Applying the latest guidelines |
| 9:15 AM CT | The Role of Artificial Intelligence in Cardiovascular Care: Case Study |
| 10:45 AM CT | Break |
| 11:00 AM CT | Product Theater |
| 11:45 AM CT | Breaking the Chain: Targeting LDL-C to Stop Atherosclerosis in Its Tracks |
| 12:30 PM CT | CE Session TBD |
| 1:15 PM CT | Closing Remarks |
Learning Objectives
Hypertension Reimagined: Applying the latest guidelines
- Discuss the key updates in the newly released hypertension guidelines and their clinical implications.
- Apply evidence-based strategies from the new guidelines to assess, monitor, and manage patients with hypertension across diverse cardiovascular care settings.
- Integrate lifestyle, pharmacologic, procedural – including renal denervation – and team-based approaches into individualized care plans to optimize blood pressure control and improve cardiovascular outcomes.
The Role of Artificial Intelligence in Cardiovascular Care: Case Study
- Discuss the supportive role of AI-driven tools in cardiovascular disease risk assessment, testing, diagnosis and monitoring
- Review considerations such as data privacy, bias in AI algorithms and strategies for integrating patient-centered approaches with AI-assisted care approaches
- Examine a case study of AI-augmentation in transthyretin amyloid cardiomyopathy (ATTR-CM) detection and diagnosis highlighting the partnership of clinician expertise with AI-driven technology
Breaking the Chain: Targeting LDL-C to Stop Atherosclerosis in Its Tracks
-
Identify and stratify patients at high risk for ASCVD, including those with familial hypercholesterolemia, elevated Lp(a) and other high-need populations, using evidence-based risk assessment tools and clinical indicators.
-
Apply current cholesterol management guidelines to improve LDL-C monitoring and optimize lipid-lowering therapy, overcoming barriers such as clinical inertia and treatment nonadherence.
-
Explore the role of the cardiovascular nurse to engage patients in shared decision-making to support long-term LDL-C control and improve access to appropriate therapies.
Thank you to BridgeBio and Medtronic for their support of this program.
Accreditation
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.
